HLB바이오스텝

278650KOSDAQ자연과학 및 공학 연구개발업

58.1 / 100

Reference Date: 2026-06-10

Financial Score21.0 / 40

News Sentiment18.1 / 25

Momentum12.0 / 20

Disclosure7.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Operating Profit is on a declining trend. Surged 133.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HLB Biosstep specializes in non-clinical CRO services, particularly in efficacy evaluation for pharmaceutical development, leveraging its expertise in high-complexity experiments using major animals like pigs and beagles. The company expanded its offerings in 2024 by acquiring HLB BioCode, a GLP toxicity testing specialist, and also provides animal facility construction and maintenance services.

Number of Employees

150people

Average Salary

61.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 62.704.0Point

PBR

0.51Industry Average 3.247.0Point

Half of industry avg (excellent)

ROE

-18.60Industry Average -32.093.5Point

Below industry avg

Debt Ratio

6.60Industry Average 7.314.0Point

In line with industry avg

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲18.7% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼441.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -9.2% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 1Negative 0Average Sentiment Score 72.5

Positive
“동물실험만으론 부족하다”…HLB바이오스텝, 차세대 비임상 플랫폼...
HLB바이오스텝이 차세대 비임상 평가 기술 개발로 미래 시장 경쟁력 강화를 예고.
Positive
HLB바이오스텝 자회사, 환경부 화학물질 유해성시험자료 생산사업 수.....
HLB바이오스텝 자회사 HLB바이오코드가 환경부 주관 국가사업 수주로 GLP 기반 독성시험 역량을 인정받아 긍정적인 시장 반응을 보임.
Positive
애드바이오텍, 임시주총서 사업 목적 추가·신규 이사진 선임 추진
AdbioTech plans strategic expansion into bio-digital healthcare, potentially boosting HLB Bios텝 indirectly through enhanced corporate strategy and leadership.

Detailed Momentum

52-week position5.0Point

52w mid range (50%)

Current 2,975Won52-week high 4,78552-week low 1,099

1-month return6.0Point

1m +133.88% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

8 totalPositive 0Neutral 7Negative 1

Neutral주식등의대량보유상황보고서(일반)2026-06-09
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-08
Neutral주식등의대량보유상황보고서(일반)2026-06-05
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-29
Negative불성실공시법인지정예고 (공시번복)2026-05-28